These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18571334)

  • 1. Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40.
    Huang JY; Bruno AM; Patel CA; Huynh AM; Philibert KD; Glucksman MJ; Marr RA
    Neuroscience; 2008 Jul; 155(1):258-62. PubMed ID: 18571334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neprilysin-2 is an important β-amyloid degrading enzyme.
    Hafez D; Huang JY; Huynh AM; Valtierra S; Rockenstein E; Bruno AM; Lu B; DesGroseillers L; Masliah E; Marr RA
    Am J Pathol; 2011 Jan; 178(1):306-12. PubMed ID: 21224067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.
    Shirotani K; Tsubuki S; Iwata N; Takaki Y; Harigaya W; Maruyama K; Kiryu-Seo S; Kiyama H; Iwata H; Tomita T; Iwatsubo T; Saido TC
    J Biol Chem; 2001 Jun; 276(24):21895-901. PubMed ID: 11278416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
    Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
    Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEP-like endopeptidases and Alzheimer's disease [corrected].
    Marr RA; Spencer BJ
    Curr Alzheimer Res; 2010 May; 7(3):223-9. PubMed ID: 20088804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance.
    Marr RA; Hafez DM
    Front Aging Neurosci; 2014; 6():187. PubMed ID: 25165447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
    Carson JA; Turner AJ
    J Neurochem; 2002 Apr; 81(1):1-8. PubMed ID: 12067222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons.
    Hama E; Shirotani K; Masumoto H; Sekine-Aizawa Y; Aizawa H; Saido TC
    J Biochem; 2001 Dec; 130(6):721-6. PubMed ID: 11726269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of mature neprilysin in lipid rafts.
    Sato K; Tanabe C; Yonemura Y; Watahiki H; Zhao Y; Yagishita S; Ebina M; Suo S; Futai E; Murata M; Ishiura S
    J Neurosci Res; 2012 Apr; 90(4):870-7. PubMed ID: 22183801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.
    Kanemitsu H; Tomiyama T; Mori H
    Neurosci Lett; 2003 Oct; 350(2):113-6. PubMed ID: 12972166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin.
    Huang H; Bihaqi SW; Cui L; Zawia NH
    Neurotoxicology; 2011 Jun; 32(3):300-6. PubMed ID: 21315759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cells.
    Miners JS; Kehoe P; Love S
    Brain Pathol; 2011 Sep; 21(5):594-605. PubMed ID: 21382117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neprilysin protects neurons against Abeta peptide toxicity.
    El-Amouri SS; Zhu H; Yu J; Gage FH; Verma IM; Kindy MS
    Brain Res; 2007 Jun; 1152():191-200. PubMed ID: 17459354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
    Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
    Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells.
    Wang R; Wang S; Malter JS; Wang DS
    J Neurochem; 2009 Feb; 108(4):1072-82. PubMed ID: 19196432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.